Involvement of a Novel Chemokine Decoy Receptor CCX-CKR in Breast Cancer Growth, Metastasis and Patient Survival

被引:74
作者
Feng, Lan-Yun [1 ]
Ou, Zhou-Luo [1 ]
Wu, Feng-Ying [1 ]
Shen, Zhen-Zhou [1 ]
Shao, Zhi-Ming [1 ]
机构
[1] Fudan Univ, Breast Canc Inst, Canc Hosp, Dept Oncol,Shanghai Med Coll,Inst Biomed Sci, Shanghai 200032, Peoples R China
基金
中国国家自然科学基金;
关键词
LYMPH-NODE METASTASIS; LUNG-CANCER; IN-VITRO; CELLS; EXPRESSION; CXCL13; CXCR5; CCR7; SEQUESTRATION; ACTIVATION;
D O I
10.1158/1078-0432.CCR-08-2495
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The biological axes of chemokines and chemokine receptors, such as CXCR4/CXCL12, CCR7/CCL19 (CCL21), CCR9/CCL25, and CXCR5/CXCL13, are involved in cancer growth and metastasis. This study is aimed at the potential regulatory role of atypical chemokine binder CCX-CKR, as a scavenger of CCL19, CCL21, CCL25, and CXCL13, in human breast cancer. Experimental Design: The role of CCX-CKR in human breast cancer was investigated in cell lines, animal models, and clinical samples. Results: Overexpression of CCX-CKR inhibited cancer cell proliferation and invasion in vitro and attenuated xenograft tumor growth and lung metastasis in vivo. CCX-CKR can be regulated by cytokines such as interleukin-1 beta tumor necrosis factor-alpha, and IFN-gamma. Lack or low expression of CCX-CKR correlated with a poor survival rate in the breast cancer patients. A significant correlation between CCX-CKR and lymph node metastasis was observed in human breast cancer tissues. CCX-CKR status was an independent prognostic factor for disease-free survival in breast cancer patients. Conclusion: We showed for the first time that CCX-CKR is a negative regulator of growth and metastasis in breast cancer mainly by sequestration of homeostatic chemokines and subsequent inhibition of intratumoral neovascularity. This finding may lead to a new therapeutic strategy against breast cancer.
引用
收藏
页码:2962 / 2970
页数:9
相关论文
共 39 条
[11]   The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro [J].
Comerford, Iain ;
Milasta, Sandra ;
Morrow, Valerie ;
Milligan, Graeme ;
Nibbs, Robert .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (07) :1904-1916
[12]   Astrocytes express functional chemokine receptors [J].
Dorf, ME ;
Berman, MA ;
Tanabe, S ;
Heesen, M ;
Luo, Y .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 111 (1-2) :109-121
[13]   Anti-tumor responses induced by chemokine CCL19 transfected into an ovarian carcinoma model via fiber-mutant adenovirus vector [J].
Gao, JQ ;
Sugita, T ;
Kanagawa, N ;
Iida, K ;
Okada, N ;
Mizuguchi, H ;
Nakayama, T ;
Hayakawa, T ;
Yoshie, O ;
Tsutsumi, Y ;
Mayumi, T ;
Nakagawa, S .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2005, 28 (06) :1066-1070
[14]   Cutting edge: Identification of a novel chemokine receptor that binds dendritic cell- and T cell-active chemokines including ELC, SLC, and TECK [J].
Gosling, J ;
Dairaghi, DJ ;
Wang, Y ;
Hanley, M ;
Talbot, D ;
Miao, ZH ;
Schall, TJ .
JOURNAL OF IMMUNOLOGY, 2000, 164 (06) :2851-2856
[15]   Chernokine sequestration by atypical chemokine receptors [J].
Hansell, C. A. H. ;
Simpson, C. V. ;
Nibbs, R. J. B. .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 :1009-1013
[16]   Commentary: Coy decoy with a new ploy: Interceptor controls the levels of homeostatic chemokines [J].
Haraldsen, Guttorm ;
Rot, Antal .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (07) :1659-1661
[17]   A silent chemokine receptor regulates steady-state leukocyte homing in vivo [J].
Heinzel, Kornelia ;
Benz, Claudia ;
Bleul, Conrad C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (20) :8421-8426
[18]   CCL19 reduces tumour burden in a model of advanced lung cancer [J].
Hillinger, S ;
Yang, SC ;
Batra, RK ;
Strieter, RM ;
Weder, W ;
Dubinett, SM ;
Sharma, S .
BRITISH JOURNAL OF CANCER, 2006, 94 (07) :1029-1034
[19]   Cancer statistics, 2008 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Hao, Yongping ;
Xu, Jiaquan ;
Murray, Taylor ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2008, 58 (02) :71-96
[20]   Cloning of CCRL1, an orphan seven transmembrane receptor related to chemokine receptors, expressed abundantly in the heart [J].
Khoja, H ;
Wang, GL ;
Ng, CTL ;
Tucker, J ;
Brown, T ;
Shyamala, V .
GENE, 2000, 246 (1-2) :229-238